Perfromance Wealth Partners, LLC Eli Lilly & CO Transaction History

Perfromance Wealth Partners, LLC

$2.89 Billion
Q3 2024

A detailed history of Perfromance Wealth Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Perfromance Wealth Partners, LLC holds 70,198 shares of LLY stock, worth $54.7 Million. This represents 2.15% of its overall portfolio holdings.

Number of Shares

70,198

Previous 66,501 5.56%

Holding current value

$54.7 Million

Previous $60.2 Million 3.29%

% of portfolio

2.15%

Previous 2.22%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$772.14 - $960.02 $2.85 Million - $3.55 Million	3,697 Added 5.56%	70,198 $62.2 Million
Q2 2024 Jul 19, 2024	BUY	$724.87 - $909.04 $23.6 Million - $29.6 Million	32,547 Added 95.86%	66,501 $60.2 Million
Q1 2024 Apr 30, 2024	BUY	$592.2 - $792.28 $9.81 Million - $13.1 Million	16,567 Added 95.28%	33,954 $26.4 Million
Q4 2023 Jan 22, 2024	BUY	$525.19 - $619.13 $1.3 Million - $1.54 Million	2,481 Added 16.64%	17,387 $10.1 Million
Q3 2023 Oct 30, 2023	BUY	$434.7 - $599.3 $669,003 - $922,322	1,539 Added 11.51%	14,906 $8.01 Million
Q2 2023 Jul 13, 2023	BUY	$350.74 - $468.98 $692,010 - $925,297	1,973 Added 17.32%	13,367 $6.27 Million
Q1 2023 Apr 20, 2023	BUY	$310.63 - $364.82 $1.25 Million - $1.47 Million	4,032 Added 54.77%	11,394 $3.91 Million
Q4 2022 Jan 19, 2023	BUY	$321.55 - $374.67 $827,669 - $964,400	2,574 Added 53.76%	7,362 $0
Q3 2022 Oct 17, 2022	SELL	$296.48 - $337.87 $4,447 - $5,068	-15 Reduced 0.31%	4,788 $1.55 Million
Q2 2022 Jul 15, 2022	BUY	$278.73 - $327.27 $308,832 - $362,615	1,108 Added 29.99%	4,803 $1.56 Million
Q1 2022 Apr 21, 2022	BUY	$234.69 - $291.66 $64,774 - $80,498	276 Added 8.07%	3,695 $1.06 Million
Q4 2021 Feb 03, 2022	BUY	$224.85 - $279.04 $768,762 - $954,037	3,419 New	3,419 $944,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perfromance Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perfromance Wealth Partners, LLC with notifications on news.

Account

Perfromance Wealth Partners, LLC Eli Lilly & CO Transaction History